Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ANI PHARMACEUTICALS INC Director's Dealing 2016

Nov 16, 2016

31676_dirs_2016-11-16_0029c8bc-8cef-4e83-a7b1-422eb92ac367.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2016-11-15

Reporting Person: Brown Robert E. JR (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-11-15 Common Stock M 3125 $6.36 Acquired 13235 Direct
2016-11-15 Common Stock M 2333 $33.00 Acquired 15568 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-11-15 Option to Purchase $6.36 M 3125 Disposed 2023-07-11 Common Stock (3125) Direct
2016-11-15 Option to Purchase $33.00 M 2333 Disposed 2024-03-31 Common Stock (2333) Direct

Footnotes

F1: The Reporting Person acquired the shares reported in Table I via a cash exercise of the options reported in Table II.